Home > Financial Ratios > MERCURY LABORATORIES

MERCURY LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for MERCURY LABORATORIES
Please provide your vote to see the results

MERCURY LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 31.82-25.4549.263.6839.88

What is the latest Core EBITDA Growth ratio of MERCURY LABORATORIES ?

The latest Core EBITDA Growth ratio of MERCURY LABORATORIES is 31.82 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar202331.82
Mar2022-25.45
Mar202149.26
Mar20203.68
Mar201939.88

How is Core EBITDA Growth of MERCURY LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2023 31.82
Positive
Mar2022 -25.45
Negative
Mar2021 49.26
1,238.59
Mar2020 3.68
-90.77
Mar2019 39.88 -

Other Financial Ratios of MERCURY LABORATORIES


Compare Core EBITDA Growth ratio of peers of MERCURY LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MERCURY LABORATORIES ₹101.9 Cr -2.4% -4.6% 41.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹363,535.0 Cr 0.9% -6.6% 58.8% Stock Analytics
CIPLA ₹112,058.0 Cr -1% -5.6% 54.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics


MERCURY LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MERCURY LABORATORIES

-2.4%

-4.6%

41.5%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses